-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Sonoma Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2015 to Q3 2024.
- Sonoma Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $147K, a 21% decline year-over-year.
- Sonoma Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$56K, a 202% decline year-over-year.
- Sonoma Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was -$196K, a 494% decline from 2022.
- Sonoma Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$33K, a 90.1% increase from 2021.
- Sonoma Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was -$332K, a 147% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)